Search Result "dyslipidemia/ hypercholesterolemia"
Familial Hypercholesterolemia: Update and Review
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22 Issue: 2 Year: 2022 Page: 198-211
Author(s): Oscar Francisco Chacón-Camacho,Claudia Fabiola Méndez-Catalá,Juan Carlos Zenteno
Dyslipidemias and Microcirculation
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 25 Year: 2018 Page: 2921-2926
Author(s): Teresa Padró,Gemma Vilahur,Lina Badimon
Dyslipidemia and Foods
Ebook: Foods for Special Dietary Regimens
Volume: 1 Year: 2021
Author(s): Elevina Pérez Sira
Doi: 10.2174/9789814998062121010010
Management of Dyslipidemia in the Metabolic Syndrome
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 7 Issue: 2 Year: 2007 Page: 99-108
Author(s): Kathryn C. B. Tan
Gene Therapy for Familial Hypercholesterolemia
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2575-2591
Author(s): Eline Van Craeyveld, Frank Jacobs, Stephanie C. Gordts, Bart De Geest
Treating Dyslipidemias: Is Inflammation the Missing Link?
Journal: Medicinal Chemistry
Volume: 10 Issue: 7 Year: 2014 Page: 643-652
Author(s): Nikolaos Papoutsidakis, Spyridon Deftereos, Georgios Giannopoulos, Vasiliki Panagopoulou, Antonis S. Manolis, Georgios Bouras
The Role of Fibrate Treatment in Dyslipidemia: An Overview
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3124-3131
Author(s): Niki Katsiki, Dragana Nikolic, Giuseppe Montalto, Maciej Banach, Dimitri P. Mikhailidis, Manfredi Rizzo
Emerging Therapies for Dyslipidemia: Known Knowns and Known Unknowns of MTP Inhibitors
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 6 Issue: 1 Year: 2012 Page: 24-29
Author(s): Saurin K. Raval, Preeti S. Raval, Mukul R. Jain
Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial Hypercholesterolemia
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3647-3653
Author(s): Vasilios Papademetriou,Konstantinos Stavropoulos,Christodoulos Papadopoulos,Konstantinos Koutsampasopoulos,Kiriakos Dimitriadis,Kostas Tsioufis
PCSK9 Inhibitors for the Management of Dyslipidemia in People with Type 2 Diabetes: How Low is Too Low?
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 8 Year: 2021 Page: 1008-1014
Author(s): Ioannis Felekos,Grigoris V. Karamasis,Antonis N. Pavlidis